Chennai-based D2C skin and haircare brand CHOSEN has raised $5 million (approximately ₹47.5 crore) in its Series A funding round. This milestone highlights the growing momentum in Direct-to-consumer India and reinforces strong investor confidence in D2C brands India, particularly within the fast-evolving D2C beauty and skincare India segment.
The round was led by Fireside Ventures, with participation from BOLD, the corporate venture arm of L’Oréal, along with Alkem Growth Capital. The presence of such strategic investors places CHOSEN among the emerging VC-backed D2C brands and top funded D2C brands in the Indian D2C ecosystem India. The round also saw participation from angel investors, including CaratLane cofounder Avnish Anand and a cohort of practicing dermatologists, further strengthening the brand’s credibility and positioning within D2C investor insights and D2C funding news conversations.
With this latest raise, CHOSEN’s total funding has crossed $6 million, including $1.2 million raised earlier from friends and family in 2024. This reflects a strong D2C startup valuation trajectory and positions the company well within the broader D2C funding rounds landscape in India. The capital will be used to strengthen its R&D capabilities, expand its pipeline of clinically validated and evidence-based products, and scale its team and centre of excellence, aligning with long-term D2C expansion plans and D2C product launches strategy.
Founded in 2020 by Dr Renita Rajan, CHOSEN operates on a differentiated clinic-to-consumer model, combining dermatological expertise with technology-led innovation. This unique D2C business model India positions the brand at the intersection of healthcare, beauty, and wellness, making it a strong contender among latest D2C startups and D2C wellness startups. The brand offers over 55 SKUs across skincare, haircare, and wellness, catering to concerns such as pigmentation, skin texture, ageing, and hair health.
Unlike many mass-market players, CHOSEN focuses on clinically backed formulations, combining topical treatments with nutraceuticals. This approach aligns with evolving D2C consumer behavior India, where trust, efficacy, and expert-backed solutions are becoming key purchase drivers. It also strengthens its position among premium D2C brands India and sustainable D2C brands that emphasize science-led innovation over trend-driven launches.
The broader context makes this funding even more significant. According to industry insights, India’s beauty and personal care segment is among the fastest-growing categories in the D2C ecosystem India, with projections to reach $28 billion by 2030. This growth is driven by increasing digital adoption, influencer marketing for D2C, and expanding demand across Tier II and Tier III markets. CHOSEN’s growth aligns closely with these D2C market trends 2025 and highlights how specialized brands are carving strong niches.
From a competitive standpoint, CHOSEN operates alongside established dermo-cosmetic brands, yet its clinic-led, evidence-first positioning sets it apart. Its focus on research, product efficacy, and direct consumer relationships reflects strong D2C brand building stories and a clear D2C go-to-market strategy.
As part of the daily digest of D2C news in India and what’s happening in India’s D2C space today, CHOSEN’s funding underscores a larger shift. Investors are increasingly backing brands that combine science, trust, and scalability. With strong backing, a clear product philosophy, and growing market demand, CHOSEN is well-positioned to scale rapidly and emerge as a leading name in India’s D2C beauty and personal care ecosystem.
